EichorEICHOR
Location: Austin Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Austin

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · FutureSearch Trials · AbbVie · NCT06602479A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · USO-Texas Oncology-Central/South Texas · Eli Lilly and Company · NCT07218380A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-10015 Austin, TX Investigational Site · Colorado Prevention Center · NCT06024746Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Phase N/A · Ascension Seton Medical Center · Arkansas Children's Hospital Research Institute · NCT03827694Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Phase N/A · Seton Heart Institute/ UT Austin · Baylor Research Institute · NCT01904851Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
NA · Texas Cardiac Arrhythmia Research · Boston Scientific Corporation · NCT07575269Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
NA · Urology Austin · Palette Life Sciences, Inc. · NCT06496256A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Texas Oncology - Central/South Texas ( Site 8008) · Merck Sharp & Dohme LLC · NCT06136559Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Local Institution - 0187 · Bristol-Myers Squibb · NCT07106762Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study
NA · University of Melbourne · NCT07055542A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Dell Children's Medical Center of Central Texas · National Cancer Institute (NCI) · NCT05099003A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Phase 3 · Texas Oncology South Austin · BioNTech SE · NCT07365995A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Community Clinical Research · Bristol-Myers Squibb · NCT06929273Study of XB010 in Subjects With Solid Tumors
Phase 1 · NEXT Austin · Exelixis · NCT06545331Pounce™ Thrombectomy System Retrospective Registry
Phase N/A · Ascension Seton · SurModics, Inc. · NCT05868161Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Dell Children's Medical Center of Central Texas · National Cancer Institute (NCI) · NCT06172296A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · FutureSearch Trials of Neurology · Kallyope Inc. · NCT07674654Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®
NA · The University of Texas at Austin - Dell Medical School · Tela Bio Inc · NCT07070115MyokinE100 System: Closed Loop Electrical Muscle Stimulation to Mitigate ICU Acquired Weakness in Medical ICU Patients
NA · Dell Seton Medical Center at The University of Texas · Health Discovery Labs · NCT07362862An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1).
Phase 1/Phase 2 · Pathios Therapeutics Pty Ltd · NCT06634849Dose Regimen Study of SLI-F06 in Healthy Volunteers
Phase 2 · DermResearch · Scarless Laboratories, Inc. · NCT05501327A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Pa
Phase 4 · Eli Lilly and Company · NCT06857942Treatment With Endovascular Intervention for STroke Patients With Existing Disability
Phase N/A · University of Texas at Austin · University of Cincinnati · NCT05911568PSMA PET Combined With MRI for the Detection of PCa
Phase 3 · Urology Austin · Telix Pharmaceuticals (Innovations) Pty Limited · NCT07052214A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Hoffmann-La Roche · NCT06793215Balance Control and Recovery in Diabetes Peripheral Neuropathy
NA · The University of Texas at Austin · Lisa Griffin · NCT06544876A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Dell Children's Medical Center of Central Texas · Children's Oncology Group · NCT06368817A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced
Phase 1 · NEXT Austin · Kumquat Biosciences Inc. · NCT06994806Registry for Stage 2 Type 1 Diabetes
Phase N/A · Texas Diabetes & Endocrinology - Austin - North Mopac Expres · Sanofi · NCT06481904A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Dell Children's Medical Center of Central Texas · National Cancer Institute (NCI) · NCT05691478
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.